Skip to main content
Vivesto logo

Vivesto — Investor Relations & Filings

Ticker · VIVE ISIN · SE0000722365 LEI · 5493003TZPR4B7QO9L49 ST Manufacturing
Open in API
Filings indexed 1,068 across all filing types
Latest filing 2025-05-08 Interim / Quarterly Rep…
Country SE Sweden
Listing ST VIVE

About Vivesto

https://www.vivesto.com/en/

Vivesto is a specialty pharmaceutical company focused on drug development in oncology. The company aims to provide new therapeutic options for patients suffering from hard-to-treat cancers where significant medical needs exist. Its research and development efforts are centered on creating innovative treatments and enhancing the intravenous delivery of established and novel drugs. The company's lead product is Apealea, a formulation of the cancer drug paclitaxel.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Vivesto AB for the period January 1 to March 31, 2025. It contains comprehensive financial statements, management commentary, business updates, and operational highlights for the quarter. It is not a mere announcement of a report, as it contains the full text and financial data, thus fitting the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-08 Swedish
Annual Report 2024
Annual Report Classification · 100% confidence The document is titled 'VIVESTO ÅRSREDOVISNING 2024' (Vivesto Annual Report 2024). It contains comprehensive sections including a management report (Förvaltningsberättelse), corporate governance (Bolagsstyrningsrapport), financial statements (Finansiella rapporter), notes (Noter), and an auditor's report (Revisionsberättelse). This structure is characteristic of a full annual report, not an announcement or a summary. FY 2024
2025-04-08 Swedish
Kallelse till årsstämma i Vivesto AB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Kallelse till årsstämma' (Notice of Annual General Meeting) for Vivesto AB. It contains the agenda, proposals for board elections, remuneration, and voting instructions for shareholders. This falls under the category of materials provided to shareholders for an upcoming meeting, which is classified as Proxy Solicitation & Information Statement.
2025-04-08 Swedish
Notice of Annual General Meeting in Vivesto AB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Annual General Meeting' for Vivesto AB. It contains the agenda, instructions for participation, proxy information, and details on proposed resolutions (such as board elections and remuneration). This document is a solicitation of shareholder participation and voting for an upcoming meeting, which fits the definition of a Proxy Solicitation & Information Statement.
2025-04-08 English
Vivesto tecknar avtal med Kazia Therapeutics om att förvärva fullständiga rättigheter till Cantrixil
M&A Activity Classification · 95% confidence The document is a press release announcing that Vivesto AB has entered into an agreement to acquire full rights to the drug candidate Cantrixil from Kazia Therapeutics. This is a corporate announcement regarding a business development transaction (acquisition of intellectual property/rights). While it mentions 'Bifogade filer' (attached files) at the end, the document itself is the primary announcement of the M&A-related activity. Therefore, it falls under M&A Activity (TAR).
2025-03-31 Swedish
Vivesto signs deal with Kazia Therapeutics to acquire full Cantrixil rights
M&A Activity Classification · 100% confidence The document is a press release announcing a corporate acquisition of drug rights (Cantrixil) from Kazia Therapeutics. This falls under M&A activity (mergers, acquisitions, or asset purchases). While it mentions regulatory disclosure requirements, the core content is a strategic business transaction, which is best classified as M&A Activity (TAR).
2025-03-31 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.